CLINICAL_TRIALS
trial_result
· 2025-05-06
Clinical Trial Update: Intravenous Iron Metabolism in Restless Legs Syndrome [Phase 2]
Summary
A Phase 2 trial evaluating intravenous iron metabolism in restless legs syndrome has completed and posted results, sponsored by American Regent, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: American Regent, Inc. | Conditions: Restless Legs | Phase 2 | Status: COMPLETED | Results posted: 2025-05-06